SCOPUS 정보 검색 플랫폼

Archives of Dermatology

Volumn 145, Issue 6, 2009, Pages 704-706

Adalimumab vs methotrexate for the treatment of chronic plaque psoriasis

(3) Batchelor, Jonathan M a Ingram, John R b Williams, Hywel c

a ADDENBROOKE S HOSPITAL (United Kingdom)

b UNIVERSITY HOSPITAL OF WALES (United Kingdom)

c UNIVERSITY OF NOTTINGHAM (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; FOLIC ACID; METHOTREXATE; PLACEBO;

CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DRUG WITHDRAWAL; HEPATITIS; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NEPHROLITHIASIS; NOTE; OVARY DISEASE; PANCREATITIS; PRIORITY JOURNAL; PSORIASIS VULGARIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE;

EID: 67449124360 PISSN: 0003987X EISSN: 15383652 Source Type: Journal
DOI: 10.1001/archdermatol.2009.104 Document Type: Note

Times cited : (9)

References (10)

1
- 0346848881
- Changing paradigms in dermatology: Tumor necrosis factor alpha (TNF-α) blockade in psoriasis and psoriatic arthritis
- DOI 10.1016/j.clindermatol.2003.08.015
- Victor FC, Gottlieb AB, Menter A. Changing paradigms in dermatology: tumor necrosis factor alpha (TNF-alpha) blockade in psoriasis and psoriatic arthritis. Clin Dermatol. 2003;21(5):392-397. (Pubitemid 37543555)
- (2003) Clinics in Dermatology , vol.21 , Issue.5 , pp. 392-397
- Victor, F.C.¹ Gottlieb, A.B.² Menter, A.³

2
- 0042625001
- Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis
- DOI 10.1056/NEJMoa021359
- Heydendael VM, Spuls PI, Opmeer BC, et al. Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis. N Engl J Med. 2003;349(7):658-665. (Pubitemid 36975998)
- (2003) New England Journal of Medicine , vol.349 , Issue.7 , pp. 658-665
- Heydendael, V.M.R.¹ Spuls, P.I.² Opmeer, B.C.³ De Borgie, C.A.J.M.⁴ Reitsma, J.B.⁵ Goldschmidt, W.F.M.⁶ Bossuyt, P.M.M.⁷ Bos, J.D.⁸ De Rie, M.A.⁹

3
- 18944396526
- Compulsory registration of clinical trials
- DOI 10.1111/j.1365-2133.2005.06727.x
- Ormerod AD, Williams HC. Compulsory registration of clinical trials. Br J Dermatol. 2005;152(5):859-860. (Pubitemid 40704921)
- (2005) British Journal of Dermatology , vol.152 , Issue.5 , pp. 859-860
- Ormerod, A.D.¹ Williams, H.C.²

4
- 33745474699
- Accessed July 18, 2008
- World Health Organization. International Clinical Trials Registry Platform (ICTRP). http://www.who.int/ictrp/en/. Accessed July 18, 2008.
- International Clinical Trials Registry Platform (ICTRP)

5
- 9444255722
- Improving the quality of reporting of randomized controlled trials: The CONSORT statement
- DOI 10.1001/jama.276.8.637
- Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials: the CONSORT statement. JAMA. 1996;276(8):637-639. (Pubitemid 26278070)
- (1996) Journal of the American Medical Association , vol.276 , Issue.8 , pp. 637-639
- Begg, C.¹ Cho, M.² Eastwood, S.³ Horton, R.⁴ Moher, D.⁵ Olkin, I.⁶ Pitkin, R.⁷ Rennie, D.⁸ Schulz, K.F.⁹ Simel, D.¹⁰ Stroup, D.F.¹¹

6
- 39049133924
- Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: Results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasis
- DOI 10.1111/j.1365-2133.2007.08236.x
- Revicki D, Willian MK, Saurat JH, et al. Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasis. Br J Dermatol. 2008;158(3):549-557. (Pubitemid 351239150)
- (2008) British Journal of Dermatology , vol.158 , Issue.3 , pp. 549-557
- Revicki, D.¹ Willian, M.K.² Saurat, J.-H.³ Papp, K.A.⁴ Ortonne, J.-P.⁵ Sexton, C.⁶ Camez, A.⁷

7
- 67449137257
- National Institute for Health and Clinical Excellence. Adalimumab for the treatment of psoriasis. www.nice.org.uk/TA146.
- Adalimumab for the Treatment of Psoriasis

8
- 0038636510
- Randomized clinical trials for psoriasis 1977-2000: The EDEN survey
- Naldi L, Svensson A, Diepgen T, et al. Randomized clinical trials for psoriasis 1977-2000: the EDEN survey. J Invest Dermatol. 2003;120(5):738-741.
- (2003) J Invest Dermatol , vol.120 , Issue.5 , pp. 738-741
- Naldi, L.¹ Svensson, A.² Diepgen, T.³

9
- 45749116472
- Adalimumab may be better or no worse than methotrexate in the treatment of psoriasis
- DOI 10.1111/j.1365-2133.2008.08606.x
- Nijsten T, Spuls PI. Adalimumab may be better or no worse than methotrexate in the treatment of psoriasis. Br J Dermatol. 2008;159(1):257-258. (Pubitemid 351874491)
- (2008) British Journal of Dermatology , vol.159 , Issue.1 , pp. 257-258
- Nijsten, T.¹ Spuls, P.I.²

10
- 22144431885
- Contradicted and initially stronger effects in highly cited clinical research
- DOI 10.1001/jama.294.2.218
- Ioannidis JP. Contradicted and initially stronger effects in highly cited clinical research. JAMA. 2005;294(2):218-228. (Pubitemid 41043792)
- (2005) Journal of the American Medical Association , vol.294 , Issue.2 , pp. 218-228
- Ioannidis, J.P.A.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.